2315 — Biocytogen Pharmaceuticals Beijing Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$4.66bn
- HK$4.87bn
- CNY980.45m
- 60
- 13
- 100
- 63
Annual cashflow statement for Biocytogen Pharmaceuticals Beijing Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -477 | -546 | -601 | -380 | 42.9 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 237 | 61.9 | 27.5 | 131 | 140 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -29.2 | -10.2 | 96.5 | -9.88 | -141 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -225 | -366 | -303 | -76.6 | 211 |
| Capital Expenditures | -296 | -199 | -240 | -127 | -37.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 108 | 115 | 86.5 | 26.3 | -100 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -188 | -84.1 | -154 | -100 | -137 |
| Financing Cash Flow Items | 889 | 234 | 448 | -177 | -111 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 868 | 219 | 587 | -37.8 | -92 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 451 | -231 | 144 | -211 | -15.1 |